(Q38135281)

29 August 2017

title

B7-H3-mediated tumor immunology: Friend or foe? (English)

1 reference

29 August 2017

0 references

Ling Wang

1

1 reference

29 August 2017

Fu-Biao Kang

series ordinal

2

1 reference

29 August 2017

Bao-En Shan

series ordinal

3

1 reference

29 August 2017

language of work or name

English

0 references

publication date

30 September 2013

1 reference

International Journal of Cancer

29 August 2017

published in

1 reference

29 August 2017

volume

134

1 reference

29 August 2017

issue

12

1 reference

29 August 2017

page(s)

2764-2771

1 reference

Immuno-oncology: understanding the function and dysfunction of the immune system in cancer

29 August 2017

cites work

1 reference

Improving the efficacy and safety of engineered T cell therapy for cancer

21 January 2018

1 reference

Immune tolerance and transplantation

21 January 2018

1 reference

Engineered T cells for anti-cancer therapy.

21 January 2018

1 reference

A more selective costimulatory blockade of the CD28-B7 pathway.

21 January 2018

1 reference

B7-H3: a costimulatory molecule for T cell activation and IFN-gamma production

21 January 2018

1 reference

B7-h3 and its role in antitumor immunity

21 January 2018

1 reference

Fine tuning the immune response through B7-H3 and B7-H4

21 January 2018

1 reference

Characterization of mouse and human B7-H3 genes

21 January 2018

1 reference

Molecular characterization of human 4Ig-B7-H3, a member of the B7 family with four Ig-like domains.

21 January 2018

1 reference

Origination of new immunological functions in the costimulatory molecule B7-H3: the role of exon duplication in evolution of the immune system

21 January 2018

1 reference

Duplication of primate and rodent B7-H3 immunoglobulin V- and C-like domains: divergent history of functional redundancy and exon loss

21 January 2018

1 reference

B7-H3 and its relevance in cancer; immunological and non-immunological perspectives

21 January 2018

1 reference

The B7 family member B7-H3 preferentially down-regulates T helper type 1-mediated immune responses

21 January 2018

1 reference

MicroRNA miR-29 modulates expression of immunoinhibitory molecule B7-H3: potential implications for immune based therapy of human solid tumors

21 January 2018

1 reference

B7-H3 associated with tumor progression and epigenetic regulatory activity in cutaneous melanoma

21 January 2018

1 reference

B7-H3, a potential therapeutic target, is expressed in diffuse intrinsic pontine glioma

21 January 2018

1 reference

Clinical importance of B7-H3 expression in human pancreatic cancer

21 January 2018

1 reference

Tumor cell and tumor vasculature expression of B7-H3 predict survival in clear cell renal cell carcinoma

21 January 2018

1 reference

Tumor associated endothelial expression of B7-H3 predicts survival in ovarian carcinomas

21 January 2018

1 reference

B7-h3 ligand expression by primary breast cancer and associated with regional nodal metastasis.

21 January 2018

1 reference

Relationship between co-stimulatory molecule B7-H3 expression and gastric carcinoma histology and prognosis

21 January 2018

1 reference

Mouse B7-H3 induces antitumor immunity.

21 January 2018

1 reference

B7-H3 enhances tumor immunity in vivo by costimulating rapid clonal expansion of antigen-specific CD8+ cytolytic T cells

21 January 2018

1 reference

Arsenic trioxide synergizes with B7H3-mediated immunotherapy to eradicate hepatocellular carcinomas

21 January 2018

1 reference

Complete eradication of hepatocellular carcinomas by combined vasostatin gene therapy and B7H3-mediated immunotherapy

21 January 2018

1 reference

An orthotopic colon cancer model for studying the B7-H3 antitumor effect in vivo.

21 January 2018

1 reference

Triggering receptor expressed on myeloid cell-like transcript 2 (TLT-2) is a counter-receptor for B7-H3 and enhances T cell responses

21 January 2018

1 reference

Trem-like transcript 2 is expressed on cells of the myeloid/granuloid and B lymphoid lineage and is up-regulated in response to inflammation

21 January 2018

1 reference

Identification of TLT2 as an engulfment receptor for apoptotic cells

21 January 2018

1 reference

B7-H3 participates in the development of experimental pneumococcal meningitis by augmentation of the inflammatory response via a TLR2-dependent mechanism.

21 January 2018

1 reference

Expression of the costimulatory molecule B7-H3 is associated with prolonged survival in human pancreatic cancer

21 January 2018

1 reference

Identification of 4Ig-B7-H3 as a neuroblastoma-associated molecule that exerts a protective role from an NK cell-mediated lysis

21 January 2018

1 reference

B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome

21 January 2018

1 reference

Expression of immunosuppresive B7-H3 ligand by hormone-treated prostate cancer tumors and metastases

21 January 2018

1 reference

Evaluation of B7-H3 expression as a biomarker of biochemical recurrence after salvage radiation therapy for recurrent prostate cancer.

21 January 2018

1 reference

Clinical significance and regulation of the costimulatory molecule B7-H3 in human colorectal carcinoma

21 January 2018

1 reference

Tumor B7-H1 and B7-H3 expression in squamous cell carcinoma of the lung.

21 January 2018

1 reference

B7-H3 is expressed in human hepatocellular carcinoma and is associated with tumor aggressiveness and postoperative recurrence

21 January 2018

1 reference

Expression of B7-H3 in hypopharyngeal squamous cell carcinoma as a predictive indicator for tumor metastasis and prognosis.

21 January 2018

1 reference

B7-H3 and B7-H4 expression in non-small-cell lung cancer

21 January 2018

1 reference

Introns in UTRs: why we should stop ignoring them

21 January 2018

1 reference

Costimulatory protein 4IgB7H3 drives the malignant phenotype of glioblastoma by mediating immune escape and invasiveness.

21 January 2018

1 reference

Induced expression of B7-H3 on the lung cancer cells and macrophages suppresses T-cell mediating anti-tumor immune response

21 January 2018

1 reference

Non-small cell lung cancer induces an immunosuppressive phenotype of dendritic cells in tumor microenvironment by upregulating B7-H3.

21 January 2018

1 reference

The immunoregulatory protein human B7H3 is a tumor-associated antigen that regulates tumor cell migration and invasion

21 January 2018

1 reference

B7-H3 over expression in prostate cancer promotes tumor cell progression

21 January 2018

1 reference

B7-H3 silencing increases paclitaxel sensitivity by abrogating Jak2/Stat3 phosphorylation

21 January 2018

1 reference

Strong antitumor activities of IgG3 antibodies to a human melanoma-associated ganglioside

21 January 2018

1 reference

In vitro and in vivo cytotoxic activities of recombinant immunotoxin 8H9(Fv)-PE38 against breast cancer, osteosarcoma, and neuroblastoma

21 January 2018

1 reference

Intraparenchymal and intratumoral interstitial infusion of anti-glioma monoclonal antibody 8H9.

21 January 2018

1 reference

Interstitial infusion of glioma-targeted recombinant immunotoxin 8H9scFv-PE38.

21 January 2018

1 reference

Compartmental intrathecal radioimmunotherapy: results for treatment for metastatic CNS neuroblastoma

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.28474

1 reference

29 August 2017

1 reference